![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Gritgen Therapeutics Launches Commercial GMP Facility in China
Gritgen Therapeutics Co., a biotechnology company focused on gene therapy products, reported the successful validation...
Cellipont and Diakonos to develop cell therapy for glioblastoma
Cellipont Bioservices has signed an agreement with Diakonos Oncology for the development of DOC1021, a...
Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content...
Sygnature Discovery, a world-leading integrated drug discovery provider and non-clinical solutions provider, has announced a...
BioCity, AstraZeneca Partner on Treatment of Advanced HCC
BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study...
NCCS and tech firm to collaborate on Asian-prevalent cancer research
Agilent Technologies Inc. recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre...
Bharat Serums and Vaccines invests Rs 200 Cr in new biopharmaceutical manufacturing plant in...
Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant...
Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation
Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify...
Growing Demand Reshaping The Future of Aseptic Fill Finish
It's important to highlight that aseptic fill finish operations demand skilled personnel, specialized automated equipment,...
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for...
Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites
Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the...